03.25.15
Savvy move by Voyant Health.
Rather than wait to make a major announcement during American Academy of Orthopaedic Surgeons (AAOS) 2015 Annual Meeting -- where news easily can become lost amid the plethora of headlines -- the company jumped the gun and disclosed a regulatory approval before the show even began.
The Brainlab company announced on March 23 U.S. Food and Drug Administration clearance of TraumaCad Mobile, its mobile solution for pre-operative orthopedic surgical planning and digital templating. TraumaCad Mobile allows healthcare professionals and orthopedic surgeons anywhere, anytime flexibility in conducting pre-operative planning of total hip replacement surgery.
The new app is being demonstrated this week at the AAOS meeting in Las Vegas, Nev. (booth 4232).
“For over a decade, thousands of orthopedic surgeons have been using our TraumaCad technology to plan surgery. In the past several years, mobile devices have transformed how surgeons and healthcare professionals work by enhancing data access and productivity,” said Marc Mackey, general manager of Orthopedics at Brainlab. “With the mobile version of TraumaCad, digital templating can now be accessed from any web browser or iPad, enabling surgeons to be more productive while also providing access to data for better inventory management.”
TraumaCad Mobile allows fast and easy preparation for total hip replacement, using only a few simple gestures. The app features:
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to and consistency of advanced, less invasive patient treatment. Privately held since its formation in 1989, Brainlab has more than 5,000 systems installed in about 95 countries.
Rather than wait to make a major announcement during American Academy of Orthopaedic Surgeons (AAOS) 2015 Annual Meeting -- where news easily can become lost amid the plethora of headlines -- the company jumped the gun and disclosed a regulatory approval before the show even began.
The Brainlab company announced on March 23 U.S. Food and Drug Administration clearance of TraumaCad Mobile, its mobile solution for pre-operative orthopedic surgical planning and digital templating. TraumaCad Mobile allows healthcare professionals and orthopedic surgeons anywhere, anytime flexibility in conducting pre-operative planning of total hip replacement surgery.
The new app is being demonstrated this week at the AAOS meeting in Las Vegas, Nev. (booth 4232).
“For over a decade, thousands of orthopedic surgeons have been using our TraumaCad technology to plan surgery. In the past several years, mobile devices have transformed how surgeons and healthcare professionals work by enhancing data access and productivity,” said Marc Mackey, general manager of Orthopedics at Brainlab. “With the mobile version of TraumaCad, digital templating can now be accessed from any web browser or iPad, enabling surgeons to be more productive while also providing access to data for better inventory management.”
TraumaCad Mobile allows fast and easy preparation for total hip replacement, using only a few simple gestures. The app features:
- Auto hip replacement planning: Automatically aligns implants and assembles components to calculate leg length discrepancy and offset. These automated steps allow physicians to simply fine tune the automatic planning.
- Device independence: Based on HTML 5 technology, TraumaCad Mobile can be accessed on iOS devices, or on PC or Mac web browsers, making digital templating available on more devices.
- Automatic calibration: Supports KingMark, a patient friendly calibration marker for AP pelvis, as well as standard spherical markers and manual oversize.
- Comprehensive template library: Includes an extensive, regularly updated library of hip digital templates with interactive sizing, positioning, and optimization.
- Collaboration and inventory management: Used with Quentry image sharing service by Brainlab, plans can be shared to better predict inventory and instrumentation requirements.
- For Enterprise or Single User: TraumaCad Mobile can be integrated with existing PACS systems with enterprise grade security and administrative management, or can be used stand-alone.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to and consistency of advanced, less invasive patient treatment. Privately held since its formation in 1989, Brainlab has more than 5,000 systems installed in about 95 countries.